Rj. Perrin et al., Interaction of human alpha-synuclein and Parkinson's disease variants withphospholipids - Structural analysis using site-directed mutagenesis, J BIOL CHEM, 275(44), 2000, pp. 34393-34398
alpha -Synuclein has been centrally implicated in neurodegenerative disease
, and a normal function in developmental synaptic plasticity has been sugge
sted by studies in songbirds. A variety of observations suggest the protein
partitions between membrane and cytosol, a behavior apparently conferred b
y a conserved structural similarity to the exchangeable apolipoproteins. He
re we show that the capacity to bind lipids is broadly distributed across e
xons 3, 4, and 5 (encoding residues 1-102), Binding to phosphatidylserine-c
ontaining vesicles requires the presence of all three exons, while binding
to phosphatidic acid can be mediated by any one of the three. Consistent wi
th a "class A2" helical binding mechanism, lipid association is disrupted b
y introduction of charged residues along the hydrophobic face of the predic
ted cu-helix and also by biotinylation of conserved lysines (which line the
interfacial region). Circular dichroism spectroscopy reveals a general cor
relation between the amount of lipid-induced alpha -helix content and the d
egree of binding to PS-containing vesicles. Two point mutations associated
with Parkinson's disease have little (A30P) or no (A53T) effect on lipid bi
nding or a-helicity. These results are consistent with the hypothesis that
alpha -synuclein's normal functions depend on an ability to undergo a large
conformational change in the presence of specific phospholipids.